News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
871,174 Results
Type
Article (88058)
Company Profile (825)
Press Release (782271)
Multimedia
Podcasts (199)
Webinars (29)
Section
Business (233305)
Career Advice (4148)
Deals (39887)
Drug Delivery (151)
Drug Development (91447)
Employer Resources (205)
FDA (18406)
Job Trends (17433)
News (398005)
Policy (39976)
Tag
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (3014)
Academic (2)
Accelerated approval (34)
Adcomms (36)
Allergies (153)
Alliances (56982)
ALS (183)
Alzheimer's disease (1807)
Antibody-drug conjugate (ADC) (353)
Approvals (18590)
Artificial intelligence (643)
Autoimmune disease (175)
Automation (40)
Bankruptcy (406)
Best Places to Work (12634)
BIOSECURE Act (23)
Biosimilars (205)
Biotechnology (490)
Bladder cancer (165)
Brain cancer (66)
Breast cancer (673)
Cancer (5121)
Cardiovascular disease (455)
Career advice (3572)
Career pathing (41)
CAR-T (312)
CDC (59)
Celiac Disease (2)
Cell therapy (852)
Cervical cancer (38)
Clinical research (77152)
Collaboration (1868)
Company closure (5)
Compensation (1190)
Complete response letters (74)
COVID-19 (2996)
CRISPR (99)
C-suite (902)
Cystic fibrosis (155)
Data (6386)
Decentralized trials (2)
Denatured (73)
Depression (153)
Diabetes (541)
Diagnostics (7256)
Digital health (51)
Diversity (13)
Diversity, equity & inclusion (49)
Drug discovery (314)
Drug pricing (227)
Drug shortages (36)
Duchenne muscular dystrophy (246)
Earnings (100298)
Editorial (66)
Employer branding (25)
Employer resources (174)
Events (135279)
Executive appointments (1044)
FDA (21652)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (11)
Frontotemporal dementia (24)
Funding (1585)
Gene editing (219)
Generative AI (68)
Gene therapy (688)
GLP-1 (1145)
Government (5455)
Grass and pollen (8)
Guidances (387)
Healthcare (20957)
HIV (66)
Huntington's disease (50)
IgA nephropathy (86)
Immunology and inflammation (301)
Immuno-oncology (65)
Indications (109)
Infectious disease (3291)
Inflammatory bowel disease (207)
Inflation Reduction Act (17)
Influenza (125)
Intellectual property (255)
Interviews (816)
IPO (17966)
IRA (60)
Job creations (5201)
Job search strategy (2866)
JPM (71)
Kidney cancer (17)
Labor market (95)
Layoffs (661)
Leadership (40)
Legal (10162)
Liver cancer (99)
Longevity (16)
Lung cancer (689)
Lymphoma (385)
Machine learning (45)
Management (66)
Manufacturing (880)
MASH (177)
Medical device (15053)
Medtech (15110)
Mergers & acquisitions (23009)
Metabolic disorders (1432)
Multiple sclerosis (170)
NASH (23)
Neurodegenerative disease (365)
Neuropsychiatric disorders (104)
Neuroscience (3160)
Neurotech (1)
NextGen: Class of 2026 (7709)
Non-profit (5114)
Now hiring (68)
Obesity (697)
Opinion (337)
Ovarian cancer (171)
Pain (218)
Pancreatic cancer (235)
Parkinson's disease (303)
Partnered (39)
Patents (517)
Patient recruitment (504)
Peanut (61)
People (66992)
Pharmaceutical (145)
Pharmacy benefit managers (33)
Phase 1 (23841)
Phase 2 (33484)
Phase 3 (25214)
Pipeline (5373)
Policy (341)
Postmarket research (3554)
Preclinical (10700)
Press Release (72)
Prostate cancer (253)
Psychedelics (58)
Radiopharmaceuticals (305)
Rare diseases (942)
Real estate (7442)
Recruiting (81)
Regulatory (29134)
Reports (68)
Research institute (2732)
Resumes & cover letters (651)
Rett syndrome (28)
RNA editing (21)
RSV (85)
Schizophrenia (160)
Series A (263)
Series B (204)
Service/supplier (30)
Sickle cell disease (104)
Special edition (27)
Spinal muscular atrophy (178)
Sponsored (48)
Startups (4336)
State (2)
Stomach cancer (20)
Supply chain (114)
Tariffs (101)
The Weekly (124)
Vaccines (1162)
Venture capital (99)
Weight loss (480)
Women's health (94)
Worklife (22)
Date
Today (135)
Last 7 days (679)
Last 30 days (2296)
Last 365 days (32856)
2026 (3485)
2025 (33230)
2024 (38141)
2023 (42567)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51337)
2018 (39122)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1290)
Alabama (92)
Alaska (7)
Arizona (347)
Arkansas (14)
Asia (51613)
Australia (9064)
California (11729)
Canada (3368)
China (1195)
Colorado (500)
Connecticut (508)
Delaware (352)
Europe (118602)
Florida (1725)
Georgia (375)
Hawaii (4)
Idaho (68)
Illinois (976)
India (72)
Indiana (552)
Iowa (24)
Japan (442)
Kansas (133)
Kentucky (43)
Louisiana (30)
Maine (83)
Maryland (1470)
Massachusetts (8632)
Michigan (365)
Minnesota (669)
Mississippi (6)
Missouri (142)
Montana (36)
Nebraska (29)
Nevada (127)
New Hampshire (86)
New Jersey (3152)
New Mexico (33)
New York (3094)
North Carolina (1636)
North Dakota (10)
Northern California (5633)
Ohio (359)
Oklahoma (23)
Oregon (55)
Pennsylvania (2341)
Puerto Rico (25)
Rhode Island (50)
South America (1664)
South Carolina (67)
South Dakota (1)
Southern California (4529)
Tennessee (180)
Texas (1853)
United States (42287)
Utah (352)
Vermont (1)
Virginia (295)
Washington D.C. (88)
Washington State (986)
West Virginia (4)
Wisconsin (132)
Wyoming (2)
There are 871,174 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Editorial
All the Ways Moderna’s Flu Vaccine Rejection Letter Shocked Us
The FDA issued a rare Refusal-to-File letter to Moderna over its mRNA-based influenza vaccine application, in an unusual move that sent the biotech’s shares tumbling.
February 11, 2026
·
4 min read
·
Dan Samorodnitsky
Press Releases
Envoy Medical Announces Pricing of Up to $78.0 Million Upsized Public Offering
$30.0 million upfront with up to an additional $48.0 million of potential aggregate gross proceeds upon the exercise in full of milestone-linked warrants for cash
February 11, 2026
·
6 min read
Press Releases
The Agency Worldwide Celebrates Four Decades of Advancing Leadership in Life Sciences Organizations
February 11, 2026
·
1 min read
Press Releases
Neurala Biosciences Reports Phase 1 Data Supporting Advancement of Second-Generation DMT–Harmala Candidates NBX-100 and NBX-200
February 11, 2026
·
1 min read
Job Trends
Hiring Outlook: January Brings Year-Over-Year Layoff Decline
Last month, biopharmas let go or projected they would let go of less than 500 people combined, based on
BioSpace
estimates, down almost 1,000 from January 2025. Still, competition for open jobs remains strong, with employed and unemployed biotech and pharma professionals eyeing their next roles.
February 11, 2026
·
4 min read
·
Angela Gabriel
Gene therapy
In Vivo Is Having a Moment as Cell and Gene Therapy Sector Gathers in San Diego
A recurring theme Tuesday morning at Phacilitate’s Advanced Therapies Week was the quickly emerging potential of in vivo approaches to cell and gene therapy—a trend also reflected in recent investments by Eli Lilly and Regeneron.
February 11, 2026
·
4 min read
·
Heather McKenzie
Manufacturing
PharmaEssentia Shores up Supply with $46M Investment in Puerto Rico Plant
The Taiwan-based company is establishing a manufacturing center for the U.S. market.
February 11, 2026
·
2 min read
·
Nick Paul Taylor
MASH
Madrigal Dives Further Into MASH With up to $4.4B siRNA Deal With Chinese Biotech
The pact between Madrigal Pharmaceuticals and Ruzhou Ribo Life Sciences could complement the former’s Rezdiffra, the first FDA-approved therapy for MASH. That drug made $287.3 million in the third quarter of 2025.
February 11, 2026
·
2 min read
·
Tristan Manalac
Press Releases
Thermo Fisher Scientific Expands Real-World Data Interoperability and Linkage Through Strategic Collaboration with Datavant
February 11, 2026
·
3 min read
Press Releases
NashBio Announces Key Leadership Roles, Advancing Technological Enablement and Access to Real-World Data
February 11, 2026
·
2 min read
1 of 87,118
Next
